Clinical Trial Update: Study of 3D189 in Patients With Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of 3D189 in hematologic malignancies is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• 3D189 (3D189)

Snippet

Sponsor: 3D Medicines | Conditions: Acute Leukemia, Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING